Wang‐Shick Ryu
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 1%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 45
- Hepatitis B Virus Studies 39
- Herpesvirus Infections and Treatments 5
- Hepatology 29
- Hepatitis C virus research 29
- Co-authors
- Haifeng Wang (1 shared paper)John M. Taylor (5 shared papers)M. Bayer (2 shared papers)Janet E. Mertz (3 shared papers)Chunkyu Ko (6 shared papers)Dong-Kyun Ryu (8 shared papers)Young-Min Park (1 shared paper)Seungtaek Kim (4 shared papers)
- Journals
- Journal of Virology (15 papers)Molecules and Cells (4 papers)Virology (4 papers)Journal of Hepatology (4 papers)Journal of General Virology (4 papers)
- Partner nations
- South KoreaUnited StatesGermany
In The Last Decade
Wang‐Shick Ryu
78 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 106
- Hepatology 1.1k
- Epidemiology 1.5k
- Virology 150
- Infectious Diseases 453
- Immunology 286
Countries citing papers authored by Wang‐Shick Ryu
This map shows the geographic impact of Wang‐Shick Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang‐Shick Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang‐Shick Ryu more than expected).
Fields of papers citing papers by Wang‐Shick Ryu
This network shows the impact of papers produced by Wang‐Shick Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang‐Shick Ryu. The network helps show where Wang‐Shick Ryu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wang‐Shick Ryu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 193 | |
| 2 | Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. | 2001 | 187 |
| 3 | 2010 | 181 | |
| 4 | 2018 | 172 | |
| 5 | 1992 | 166 | |
| 6 | 2009 | 117 | |
| 7 | 1989 | 93 | |
| 8 | 1993 | 84 | |
| 9 | 2004 | 84 | |
| 10 | 2020 | 82 | |
| 11 | 2014 | 73 | |
| 12 | 2001 | 72 | |
| 13 | 2000 | 71 | |
| 14 | 2009 | 71 | |
| 15 | 2014 | 59 | |
| 16 | 2010 | 57 | |
| 17 | 2019 | 57 | |
| 18 | 2009 | 54 | |
| 19 | 1995 | 52 | |
| 20 | 2016 | 43 |
About Wang‐Shick Ryu
Wang‐Shick Ryu is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Molecular Biology and Genetics, having authored 79 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (39 papers), Hepatitis C virus research (29 papers), Viral gastroenteritis research and epidemiology (17 papers), Virus-based gene therapy research (9 papers), Animal Virus Infections Studies (9 papers), RNA Interference and Gene Delivery (8 papers), Bacteriophages and microbial interactions (8 papers) and Herpesvirus Infections and Treatments (5 papers). The work is most often cited by research in Hepatology (1.1k citations), Epidemiology (1.5k citations), Virology (150 citations), Infectious Diseases (453 citations) and Immunology (286 citations). Wang‐Shick Ryu has collaborated with scholars based in South Korea, United States and Germany. Frequent co-authors include Haifeng Wang, John M. Taylor, M. Bayer, Janet E. Mertz, Chunkyu Ko, Dong-Kyun Ryu, Young-Min Park, Haifeng Wang, Seungtaek Kim and Marc P. Windisch. Their work appears in journals such as Journal of Virology, Molecules and Cells, Virology, Journal of Hepatology and Journal of General Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.